News | Radiology Business | January 25, 2016

GlobalData: Medical Device Excise Tax Suspension Will Rejuvenate U.S. Market

Analyst says two-year suspension will bring relief for small and mid-sized companies, but pros and cons of 2018 reinstatement need to be weighed

medical device excise tax, two-year suspension, U.S. market, GlobalData analyst

January 25, 2016 — The suspension of the medical device excise tax will have positive consequences for the U.S. medical device market over the next few years, says an analyst with research and consulting firm GlobalData.

The tax, which was implemented in 2013 as part of the Patient Protection and Affordable Care Act (PPACA, also known as Obamacare), imposed a 2.3 percent tax on the domestic sales of medical devices in the United States, to be paid by manufacturers or importers. It was suspended on Dec. 18, 2015, after the Consolidated Appropriations Act 2016 was signed, which induces a two-year moratorium on the tax, effective Jan. 1, 2016 to Dec. 31, 2017. 

According to Jennifer Ryan, GlobalData’s analyst covering medical devices, the tax was originally implemented to generate around $30 billion in funds to support the PPACA, under the assumption that greater access to healthcare coverage would create a larger market for medical devices. However, the first half of 2013 saw the tax raising only 60 percent of the expected amount.

Ryan expanded: “As well as lacking effectiveness, the tax had many costly consequences for manufacturers, and was particularly crippling to smaller companies, which were forced to face challenges such as layoffs, cuts to research and development efforts, and delayed expansion plans.

“The tax also threatened to seize much of the money spent on product innovation and advancement in the U.S. medical device market, which was already struggling under stringent regulatory and reimbursement procedures.”

The analyst adds that there were further concerns that patient welfare would be affected by U.S. companies looking to market products through distribution channels overseas in order to avoid strict regulations, thereby preventing U.S. patients from accessing the latest technologies.

GlobalData believes the repeal of the act will be a relief to small and mid-sized companies, which were struggling under its weight over the past three years. However, this will be short-lived unless further legislative action is taken, and as the medical device excise tax is set to be automatically reinstated on Jan. 1, 2018.

Ryan concluded: “While there are clear arguments for making the repeal permanent, there are other consequences to take into account, as funds originally garnered from the medical device excise tax, largely used to back the PPACA, will need to be found elsewhere to prevent any negative effects on the U.S. healthcare market.”

For more information: www.globaldata.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
MDW Unveils First Radiology Blockchain Platform at RSNA 2018
News | Radiology Business | November 13, 2018
Medical Diagnostic Web (MDW) will debut the first radiology blockchain platform designed to connect all players in the...
Charles Ananian, M.D.

Charles Ananian, M.D.

Sponsored Content | Case Study | Digital Radiography (DR) | November 07, 2018
Whether it’s a premature baby or a critically ill child, treating little patients is a huge responsibility.
An enhanced patient experience can reduce providers’ exposure to liability, increase care compliance and positively impact providers’ reputations in the care community.

An enhanced patient experience can reduce providers’ exposure to liability, increase care compliance and positively impact providers’ reputations in the care community.

Feature | Radiology Business | November 06, 2018 | By Casey Williams
Two unrelenting forces are on a crash-course in healthcare: The rising volume of patient out-of-pocket payments and i
Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Sponsored Content | Case Study | Computed Tomography (CT) | November 06, 2018
The following is a summary of a study published in the
National Radiologic Technology Week Celebrates Being "Powerful Together" in 2018

Image courtesy of the American Society of Radiologic Technologists

News | Radiology Business | November 02, 2018
Radiologic technologists perform hundreds of millions of diagnostic imaging and radiation therapy procedures every year...
Cardiac Ultrasound Software Streamlines Fetal Heart Exams
Feature | Cardiovascular Ultrasound | October 30, 2018
A new tool called fetalHQ on GE Healthcare’s Voluson ultrasound systems is the first tool to simultaneously examine the...
Hitachi Supports ASE Foundation Cardiovascular Outreach Mission in West Virginia
News | Cardiovascular Ultrasound | October 29, 2018
Hitachi Healthcare Americas participated in the cardiovascular screening and diagnostic triage event that took place...